Do insulin-like growth factors underlie associations of birth complications, fetal and pre-adult growth with schizophrenia? [4]

Schizophrenia Research

Volumn 67, Issue 2-3, 2004, Pages 309-311

  Gunnell, D ^a   Holly, J M P ^b  

^a Canynge Hall ^*  (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C;

AMINO ACID SEQUENCE; BLOOD BRAIN BARRIER; BODY HEIGHT; BODY MASS; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN VENTRICLE; CALORIC INTAKE; CELL SURVIVAL; COGNITION; DENDRITIC CELL; FETUS; FETUS GROWTH; GENE LOCATION; HORMONE ACTION; HUMAN; LETTER; LOW BIRTH WEIGHT; MENTAL DEFICIENCY; MYELINATION; NEUROPROTECTION; NONHUMAN; PHYSICAL DEVELOPMENT; POSTNATAL GROWTH; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SCHIZOPHRENIA; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; SYNAPTOGENESIS; TRANSGENIC MOUSE;

EID: 1342343044     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00180-4     Document Type: Letter

References (31)

1. Berkman D.S., Lescano A.G., Gilman R.H., Lopez S.L., Black M.M. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet. 359:2002;564-571.
2. Catts V.S., Catts S.V. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr. Res. 41:2000;405-415.
3. Chang S., Spitz M.R., Yu H., Xifeng W. Insulin-like growth factors (IGFs) in post-menopausal women: looking closely at body size and reproductive factors. Proc. Am. Assoc. Cancer Res. 42:2001.
4. Davey Smith G., Gunnell D., Holly J. Insulin-like growth factor-I and cancer. Epidemiological insights into a potential mechanism linking environment and cancer risk. BMJ. 321:2000;847-848.
5. DeLisi L.E., Shaw S.H., Crow T.J., Shields G., Smith A.B., Larach V.W., Wellman N., Loftus J., Nanthakumar B., Razi K., Stewart J., Comazzi M., Vita A., Heffner T., Sherrington R. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry. 159:2002;803-812.
6. Doublier S., Duyckaerts C., Seurin D., Binoux M. Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Growth Horm. IGF Res. 10:2000;267-274.
7. Fall C.H.D., Pandit A.N., Law C.M., Yajnik C.S., Clark P.M., Breier B., Osmond C., Shiell A.W., Gluckman P.D., Barker D.J.P. Size at birth and plasma insulin-like growth factor-1 concentrations. Arch. Dis. Child. 73:1995;287-293.
8. Gluckman P.D., Guan J., Williams C., Scheepens A., Zhang R., Bennet L., Gunn A. Asphyxial brain injury - the role of the IGF system. Mol. Cell. Endocrinol. 140:1998;95-99.
9. Guevara-Aguirre J., Rosenbloom A.L., Fielder P.J., Diamond F.B., Rosenfeld R.G. Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations. J. Clin. Endocrinol. Metab. 76:1993;417-423.
10. Gunnell D., Rasmussen F., Fouskakis D., Tynelius P., Harrison G. Patterns of fetal and childhood growth and the development of psychosis in young males: a cohort study. Am. J. Epidemiol. 158:2003;291-300.
11. Holly J.M.P., Gunnell D.J., Davey Smith G. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol. 162:1999;321-330.
12. Jernström H., Olsson H. Insulin-like growth factor-1 in relation to adult weight and birth weight in healthy nulliparous women. Int. J. Gynecol. Obstet. 62:1998;11-18.
13. Juul A., Bang P., Hertel N.T., Main K., Dalgaard P., Jorgensen K., Müller J., Hall K., Skakkebæk N.E. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J. Clin. Endocrinol. Metab. 78:1994;744-752.
14. Kaklamani V.G., Linos A., Kaklamani E., Markaki I., Koumantaki Y., Mantzoros C.S. Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J. Clin. Oncol. 17:1999;3291-3298.
15. Kunugi H., Nanko S., Murray R.M. Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br. J. Psychiatry. 40:2001;S25-S29.
16. Laron Z., Klinger B. Laron syndrome: clinical features, molecular pathology and treatment. Horm. Res. 42:1994;198-202.
17. Le Roith D. Insulin-like growth factors. N. Engl. J. Med. 336:1997;633-640.
18. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A., Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry. 58:2001;573-578.
19. Niblock M.M., Brunso-Bechtold J.K., Riddle D.R. Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex. J. Neurosci. 20:2000;4165-4176.
20. Niculescu A.B. III, Segal D.S., Kuczenski R., Barrett T., Hauger R.L., Kelsoe J.R. Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol. Genomics. 4:2000;83-91.
21. Nopoulos P., Flaum M., Arndt S., Andreasen N. Morphometry in schizophrenia revisited: height and its relationship to pre-morbid function. Psychol. Med. 28:1998;655-663.
22. Ong K., Kratzsch J., Kiess W., Costello M., Scott C., Dunger D. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. J. Clin. Endocrinol. Metab. 85:2000;4266-4269.
23. Richards M., Hardy R., Kuh D., Wadsworth M.E. Birth weight and cognitive function in the British 1946 birth cohort: longitudinal population based study. BMJ. 322:2001;199-203.
24. Singer K., Chang P.T., Hsu G.L. Physique, personality and mental illness in the Southern Chinese. Br. J. Psychiatry. 121:1972;315-319.
25. Torres-Aleman I. Serum growth factors and neuroprotective surveillance: focus on IGF-1. Mol. Neurobiol. 21:2000;153-160.
26. Tsuang M.T., Stone W.S., Faraone S.V. Genes, environment and schizophrenia. Br. J. Psychiatry. 40:2001;S18-S24.
27. Vatten L.J., Odeg R.A., Nilsen S.T., Salvesen K., Austgulen R. Relationship of insulin-like growth factor-I and insulin-like growth factor binding proteins in umbilical cord plasma to preeclampsia and infant birthweight. Obstet. Gynaecol. 99:2002;85-90.
28. Wahlbeck K., Forsen T., Osmond C., Barker D.J., Eriksson J.G. Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood. Arch. Gen. Psychiatry. 58:2001;48-52.
29. Ward K.E., Friedman L., Wise A., Schulz S.C. Meta-analysis of brain and cranial size in schizophrenia. Schizophr. Res. 22:1996;197-213.
30. Woods K.A., Camacho-Hubner C., Savage M.O., Clark A.J. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 335:1996;1363-1367.
31. Yu H., Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92:2000;1472-1489.